S-1 in the Treatment of Advanced and Recurrent Gastric Cancer: Current State and Future Prospects

Gastric Cancer - Germany
doi 10.1007/s10120-003-0228-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Longterm Control of Advanced and Recurrent Gastric Cancer (ARGC) by S-1

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2003English

Advanced Imaging in Femoroacetabular Impingement: Current State and Future Prospects

Frontiers in Surgery
Surgery
2015English

S-1 With Leucovorin and Oxaliplatin for Advanced Gastric Cancer

The Lancet Oncology
Oncology
2016English

Chemoprevention of Cancer: Current Evidence and Future Prospects

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2015English

Combination Therapy With Docetaxel and S-1 as a First-Line Treatment in Patients With Advanced or Recurrent Gastric Cancer: A Retrospective Analysis

World Journal of Surgical Oncology
SurgeryOncology
2010English

Current State and Future Prospects for Liquid Biofuels in Canada

Biofuel Research Journal
BiotechnologySustainabilitythe EnvironmentFuel TechnologyRenewable Energy
2018English

Knowledge Integration in Cancer: Current Landscape and Future Prospects

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Nutrients in the Chemoprevention of Prostate Cancer: Current and Future Prospects

Cancer Control
MedicineOncologyHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy